Patent ID: 8980945
Filing Date: 2015-03-17
Classification: A61K,A61P,Y02A

Abstract:
1. An antiviral composition, comprising: a pharmaceutically acceptable carrier suitable for oral or parenteral use in admixture with a synergistic combination of (−)-Carvone, (+)-Carvone, Trans-Geraniol, and at least one more component selected from the group consisting of Eugenol methylether, Linalooloxide, (cis+trans)-1,2-(+)-Limonene oxide, (+/−)-Isomenthol, Eugenol, Trans-Nerolidol, (cis+trans)-Nerolidol, and Lavendulol; wherein the synergistic combination comprises between 10 and 35 wt % (−)-Carvone, between 10 and 35 wt % (+)-Carvone, between 10 and 35 wt % Trans-Geraniol, and at least 0.5 wt % of the at least one more component and is synergistic with respect to an antiviral effect of the (−)-Carvone, (+)-Carvone, trans-geraniol, and the at least one more component; and wherein the (−)-Carvone and (+)-Carvone, the trans-Geraniol, and the at least one more component are present in the composition in an amount effective for treatment of a disease caused by at least one of a Herpes Virus, a Rotavirus, a Porcine Reproductive and Respiratory Syndrome virus, and a Papilloma virus.